In a Novo Nordisk funded study of 3,417 adults without diabetes and with a BMI of 30 or higher, or a BMI of 27 or higher with at least one obesity-related complication, participants achieved an average 20.4% weight loss with cagrilintidesemaglutide, compared with 3.0% with placebo 14
This guide explains access rules using simple language and practical explanations
The other reason investors are questioning Novo Nordisks future is that it is not seen as having as strong of a pipeline of future drugs as its rivals, particularly Eli Lilly and some others
Based on your unique physiology, they determine whether GLP-1 therapy is appropriate and recommend a custom dosage plan using semaglutide or another GLP-1 compound
You will be given a drink and a light snack
Insurance coverage often differs substantially: Medicare Part D covers Mounjaro for T2D but, as of 2026, does not generally cover Zepbound for weight management